| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2012-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b693a03de1d9f1ea5fad3c891fc680b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8148ab21e27f26a972227e14ac5e87ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a76c95441e9c0455f1bdaef34b3d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8707da53db62fc7d543302129193ce0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e27f1e8c0d807ec5643c46ebc0357de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e39b714d4d1f355bd376b23a844faf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d55408e63e225d4d635bd550c8f4aa6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df86998d8e8996ffe38fa4f1122aded0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450ef4e2be4ab07cc3bc72113fa32c88 |
| publicationDate |
2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112013022213-A2 |
| titleOfInvention |
parenteral administration of tapentadol |
| abstract |
patent summary: "parenteral administration of tapentadol". The present invention relates to an aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a ph value of at least 5.4. |
| priorityDate |
2011-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |